Author:
West Jonathan,Ogston Simon,Foerster John
Publisher
Public Library of Science (PLoS)
Reference51 articles.
1. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials;J Schmitt;The British journal of dermatology,2014
2. Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study;A Baranauskaite;Annals of the rheumatic diseases,2012
3. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1);J Barker;The British journal of dermatology,2011
4. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis;JM Bathon;The New England journal of medicine,2000
5. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial;J Braun;Arthritis and rheumatism,2008
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献